Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Chemosphere. 2023 Mar 4;324:138228. doi: 10.1016/j.chemosphere.2023.138228

Table 4.

Summary of lipid metabolites associated with total PFAS or individual PFAS in VDAART children.

VDAART Children
PFAS mixture Individual PFAS
Lipid Sub-Pathway Number of Metabolites Number in Pathway % Significant in Pathway Number of Total Associatio ns Number of Unique Metabolite s Number in Pathway % Significant in Pathway
Phosphatidylcholine (PC) 9 14 64.29 32 10 19 52.63
Lysophospholipid 9 19 47.37 28 10 26 38.46
Sphingomyelins 8 29 27.59 20 8 29 27.59
Phosphatidylinositol (PI) 3 6 50 9 3 6 50
Fatty Acid, Dicarboxylate 2 27 7.41 9 6 27 22.22
Long Chain Polyunsaturated Fatty Acid (n3 and n6) 6 15 40 7 6 15 40
Fatty Acid Metabolism (Acyl Carnitine, Long Chain Saturated) 3 8 37.5 7 3 8 37.5
Plasmalogen 2 11 18.18 4 2 11 18.18
Lysoplasmalogen 4 4 100 4 4 4 100
Fatty Acid, Monohydroxy 1 16 6.25 4 3 16 18.75
Dihydrosphingomyelins 1 5 20 4 1 5 20
Phosphatidylethanolamine (PE) 1 12 8.33 3 1 12 8.33
Long Chain Saturated Fatty Acid 2 7 28.57 3 3 7 42.86
Carnitine Metabolism 1 2 50 3 1 2 50
Androgenic Steroids 14 3 3 14 21.43
Progestin Steroids 1 5 20 2 1 5 20
Primary Bile Acid Metabolism 10 2 2 10 20
Pregnenolone Steroids 2 6 33.33 2 2 6 33.33
Fatty Acid, Dihydroxy 1 5 20 2 1 5 20
Fatty Acid, Branched 1 4 25 2 1 4 25
Fatty Acid, Amino 1 3 33.33 2 1 3 33.33
Fatty Acid Metabolism (Acyl Carnitine, Monounsaturated) 4 2 1 10 10
Ceramides 2 2 2 4 50
Sphingosines 1 2 50 1 1 2 50
Phospholipid Metabolism 1 7 14.29 1 1 7 14.29
Mevalonate Metabolism 1 1 100 1 1 1 100
Medium Chain Fatty Acid 1 9 11.11 1 1 9 11.11
Eicosanoid 1 1 100 1 1 1 100

The number of lipid metabolites significantly associated (FDR<0.05) with PFAS mixture or one of the six individual PFAS species are summarized by lipid sub-pathway. Categorization is consistent with Table 3.